Clinical Trial: Obstructive Sleep Apnea Syndrome: Evaluation of the Efficacy of Sleepinnov(c) (Spiri+) Continuous Positive Airway Pressure Device

U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT04141176) titled 'Obstructive Sleep Apnea Syndrome: Evaluation of the Efficacy of Sleepinnov(c) (Spiri+) Continuous Positive Airway Pressure Device' on Oct. 24.

Brief Summary: Continuous Positive Airway Pressure (CPAP) is the reference treatment of patients suffering from Obstructive Sleep Apnea Syndrome (OSAS).This device functions as a pneumatic stent that stabilizes the upper airway, prevents periodic collapses during sleep.The correction of abnormal respiratory events during sleep allows improvement of symptoms related to OSAS and restores quality of life.The purpose of this study is to validate the efficacy of a new CPAP brand developed by Sleep...